Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients

Flavio A. Cadegiani, Andy Goren, Carlos G. Wambier, John McCoy
doi: https://doi.org/10.1101/2020.10.31.20223883

Data Availability

Full raw data is available at a public repository (https://osf.io/cm4f8/).

https://osf.io/cm4f8/

Back to top
Posted November 04, 2020.
Download PDF
Data/Code
Email
Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients
Flavio A. Cadegiani, Andy Goren, Carlos G. Wambier, John McCoy
medRxiv 2020.10.31.20223883; doi: https://doi.org/10.1101/2020.10.31.20223883
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area